2023 annual financial data
PharmaCyte Biotech, Inc. 2023 Operating margin
PharmaCyte Biotech, Inc. 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -6,455,000 USD and net income was -4,316,000 USD.
Operating cash flow was -3,793,731 USD.
Get free PharmaCyte Biotech, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -6,455,000 USD
- Net income
- -4,316,000 USD
- Operating cash flow
- -3,793,731 USD